Marco Zarbin, MD, PhD
Show Description +
Marco Zarbin, MD, PhD, recaps his FLOREtina talk, which covered two classes of drugs (Tie-2 receptor signaling inhibitors and VEGF traps) being examined for the treatment of diabetic retinopathy. Dr. Zarbin explains how each drug class works and reviews several clinical trials involving different compounds and molecules in each category.
Posted: 4/27/2017
Marco Zarbin, MD, PhD
Marco Zarbin, MD, PhD, recaps his FLOREtina talk, which covered two classes of drugs (Tie-2 receptor signaling inhibitors and VEGF traps) being examined for the treatment of diabetic retinopathy. Dr. Zarbin explains how each drug class works and reviews several clinical trials involving different compounds and molecules in each category.
Posted: 4/27/2017
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of FLORetina: 2017.
Please log in to leave a comment.